This is because human GBM tumors are comprised of a mix of malignant glioma (cancer) cells with genetic alterations like homozygous MTAP-deletion and non-transformed non-malignant stromal cells (e.g., myeloid cells). This evidence concerns the gene MTAP and cancer.